Live Breaking News & Updates on Lis Stock

Stay updated with breaking news from Lis stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TLIS 2-DAY DEADLINE ALERT: Hagens Berman, National Trial

SAN FRANCISCO, March 06, 2022 (GLOBE NEWSWIRE) Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to. ....

Hagens Berman , Reed Kathrein , Talis Biomedical Corporation , Plaintiff Deadline , Biomedical Corporation , Securities Class Action , Talis One , Disease Control , Talis Biomedical , Hagens Berman Sobol Shapiro Llp , Lis Class Action , Lis Fraud , Lis Investor , Lis Investor Fraud , Lis Lawsuit , Lis Securities Fraud , Lis Stock , Lis Securities , Lass Action ,

TLIS 8-DAY DEADLINE ALERT: Hagens Berman, National Trial

SAN FRANCISCO, Feb. 28, 2022 (GLOBE NEWSWIRE) Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to. ....

Hagens Berman , Reed Kathrein , Talis Biomedical Corporation , Plaintiff Deadline , Biomedical Corporation , Securities Class Action , Talis One , Disease Control , Talis Biomedical , Hagens Berman Sobol Shapiro Llp , Lis Class Action , Lis Fraud , Lis Investor Fraud , Lis Lawsuit , Lis Securities Fraud , Lis Stock , Lis Securities , Lis Investor , Lass Action ,

TLIS INVESTOR ALERT: Hagens Berman, National Trial

SAN FRANCISCO, Feb. 07, 2022 (GLOBE NEWSWIRE) Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to. ....

Hagens Berman , Reed Kathrein , Talis Biomedical Corporation , Plaintiff Deadline , Biomedical Corporation , Securities Class Action , Talis One , Disease Control , Talis Biomedical , Hagens Berman Sobol Shapiro Llp , Lis Class Action , Lis Fraud , Lis Investor , Lis Investor Fraud , Lis Lawsuit , Lis Securities Fraud , Lis Stock , Lis Securities , Lass Action ,

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Talis

SAN FRANCISCO, Jan. 11, 2022 (GLOBE NEWSWIRE) Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to. ....

Hagens Berman , Reed Kathrein , Talis Biomedical Corporation , Plaintiff Deadline , Biomedical Corporation , Securities Class Action , Talis One , Disease Control , Talis Biomedical , Hagens Berman Sobol Shapiro Llp , Lis Class Action , Lis Investor , Lis Securities Fraud , Lis Lawsuit , Lis Stock , Lis Investor Fraud , Lis Fraud , Lis Securities , Lass Action ,

Talis Biomedical Corporation (NASDAQ:TLIS) Is Expected To Grow By Or More Than -28.76%.

In last trading session, Talis Biomedical Corporation (NASDAQ:TLIS) saw 0.34 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $4.66 trading at $0.06 or 1.30% at ring of the bell on the day assigns it a market valuation of $124.14M. That c ....

Warren Buffett , Arrowmark Colorado Holdings , Vanguard Explorer Fund Inc , Baker Brothers Advisors , Meridian Contrarian Fund , Talis Biomedical Corporation , Stocks Primed , Explode The , Biomedical Corporation , Vanguard Explorer Fund , Mutual Funds , Nasdaq Tlis , Talis Biomedical Corporation , Lis Stock ,